The previous evidence showed that MEK/ERK pathway was blocked after gastric cancer or cell lines were inhibited [28, 29], which was similar with our data that MEK/ERK pathway was inhibited in lidocaine-treated cells. This evidence concerns the gene MAP2K7 and gastric cancer.